In October 2026, researchers at Swiss Federal Institute of Technology Zurich (ETH Zurich) in Basel, Switzerland, unveiled an experimental electronic implant that could one day transform how type 2 diabetes is treated. Led by bioengineer Martin Fussenegger, the team published its findings in the journal Science, describing a wireless device the size of a USB…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
This device, which activates when the level of glucose in the blood is too high after a meal, emits an electric current that transforms excess glucose into a molecule easily excreted in the urine.